| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |